Release date: 18 November 2024
Promoter – Financial Intermediary
DRAEGERWERK AG & CO KGAALocation
Description
The project will finance the promoter's Medical Division research and development (R&D) programme for 2025-2026. The related &D investments will focus on connected health devices.
Objectives
The aim is to support R&D and new product improvements of critical care medical devices to be used in acute care departments.
Sector(s)
- Industry - Manufacturing
Proposed EIB finance (Approximate amount)
EUR 100 million
Total cost (Approximate amount)
EUR 248 million
Environmental aspects
The project concerns investments in that are expected to be carried out in existing facilities, already authorised, and which would therefore not require an environmental impact assessment (EIA) 2014/52/EU amending the EIA Directive 2011/92/EC.
Procurement
The promoter is a private company not operating in the utilities sector, and is thus not covered by EU directives on procurement.
Status
Under appraisal - 21/08/2024
Disclaimer
Before financing approval by the Board of Directors, and before loan signature, projects are under appraisal and negotiation. The information and data provided on this page are therefore indicative.
They are provided for transparency purposes only and cannot be considered to represent official EIB policy (see also the Explanatory notes).